Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raynaud's Phenomenon.

Coffman1

  • 1Peripheral Vascular Section, Evans Memorial Department of Clinical Research and Department of Medicine, Boston University Medical Center, One Boston Medical Center Place, Boston, MA 02118, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary

Raynaud's phenomenon management focuses on conservative measures for primary cases and treating underlying causes for secondary. Drug therapy, particularly calcium channel blockers, is beneficial for severe symptoms, with surgical options for refractory cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a System to Provide Full, Real-time Remote Control of a Scanning Electron Microscope across the Second Generation Internet: The Teaching SEM.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2000
Same author

First Measurement of the B--> pi l nu and B--> rho ( omega )l nu Branching Fractions.

Physical review letters·1996
Same author

Analysis of D0-->KK-barX decays.

Physical review. D, Particles and fields·1996
Same author

First observation of the decay tau --->K- eta nu tau.

Physical review letters·1996
Same author

Measurements of B-->Ds+X decays.

Physical review. D, Particles and fields·1996
Same author

Limits on flavor changing neutral currents in D0 meson decays.

Physical review letters·1996

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Dermatology

Background:

  • Raynaud's phenomenon presents as primary (idiopathic) or secondary to other conditions.
  • Primary Raynaud's is common in young women, often triggered by cold and pressure.
  • Secondary Raynaud's requires addressing the underlying disease or triggers.

Purpose of the Study:

  • To summarize current understanding and treatment strategies for Raynaud's phenomenon.
  • To differentiate management approaches for primary versus secondary Raynaud's.
  • To review therapeutic options from conservative measures to surgical interventions.

Main Methods:

  • Review of existing literature and clinical guidelines on Raynaud's phenomenon.
  • Analysis of treatment efficacy for various interventions.

Related Experiment Videos

  • Categorization of management strategies based on disease type and severity.

    • Main Results:

    • Conservative measures and reassurance are effective for many primary Raynaud's cases.
    • Avoiding cold and pressure is crucial; warm clothing and hand warmers are beneficial.
    • Calcium channel blockers (e.g., extended-release nifedipine) are first-line pharmacotherapy for severe cases.
    • Sympatholytic drugs may be used if calcium channel blockers fail or are not tolerated.
    • Digital artery sympathectomy can aid healing in severe ischemia; lumbosacral sympathectomy is effective for toe symptoms.

    Conclusions:

    • Effective management of Raynaud's phenomenon involves a stepwise approach tailored to disease type and severity.
    • Conservative and pharmacologic treatments are often sufficient, but surgical options exist for refractory cases.
    • Understanding triggers and employing preventative measures are key components of Raynaud's management.